1. Home
  2. REFR vs CPIX Comparison

REFR vs CPIX Comparison

Compare REFR & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REFR
  • CPIX
  • Stock Information
  • Founded
  • REFR 1965
  • CPIX 1999
  • Country
  • REFR United States
  • CPIX United States
  • Employees
  • REFR N/A
  • CPIX N/A
  • Industry
  • REFR Multi-Sector Companies
  • CPIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • REFR Miscellaneous
  • CPIX Health Care
  • Exchange
  • REFR Nasdaq
  • CPIX Nasdaq
  • Market Cap
  • REFR 56.9M
  • CPIX 51.5M
  • IPO Year
  • REFR N/A
  • CPIX 2009
  • Fundamental
  • Price
  • REFR $1.75
  • CPIX $2.69
  • Analyst Decision
  • REFR
  • CPIX
  • Analyst Count
  • REFR 0
  • CPIX 0
  • Target Price
  • REFR N/A
  • CPIX N/A
  • AVG Volume (30 Days)
  • REFR 131.8K
  • CPIX 38.9K
  • Earning Date
  • REFR 11-06-2025
  • CPIX 11-04-2025
  • Dividend Yield
  • REFR N/A
  • CPIX N/A
  • EPS Growth
  • REFR N/A
  • CPIX N/A
  • EPS
  • REFR N/A
  • CPIX N/A
  • Revenue
  • REFR $1,222,239.00
  • CPIX $42,071,813.00
  • Revenue This Year
  • REFR N/A
  • CPIX N/A
  • Revenue Next Year
  • REFR N/A
  • CPIX N/A
  • P/E Ratio
  • REFR N/A
  • CPIX N/A
  • Revenue Growth
  • REFR N/A
  • CPIX 11.34
  • 52 Week Low
  • REFR $0.93
  • CPIX $1.04
  • 52 Week High
  • REFR $2.70
  • CPIX $7.25
  • Technical
  • Relative Strength Index (RSI)
  • REFR 49.15
  • CPIX 30.63
  • Support Level
  • REFR $1.60
  • CPIX $2.64
  • Resistance Level
  • REFR $2.70
  • CPIX $3.40
  • Average True Range (ATR)
  • REFR 0.25
  • CPIX 0.21
  • MACD
  • REFR -0.01
  • CPIX -0.08
  • Stochastic Oscillator
  • REFR 13.64
  • CPIX 5.79

About REFR Research Frontiers Incorporated

Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. The company's revenue source comes from the licensing of technology.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: